文献速递炎症性肠病消化内镜

内镜下球囊扩张与内镜下狭窄切开术治疗短段克罗恩病狭窄:BEST-CD随机试验

Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Disease Strictures: The BEST-CD Randomized Trial.
PubMed 文献 · Clin Gastroenterol Hepatol · 2026-10-28

这项随机对照试验纳入106例有症状且狭窄长度小于3厘米的克罗恩病患者,1:1分配至内镜下球囊扩张(EBD)或内镜下狭窄切开术(ES)。1年时ES组临床复发率(30.1% vs 54.7%;

要点

  • 对于短段(<3 cm)克罗恩病狭窄,ES较EBD降低1年临床复发率。
  • ES组1年再干预、急诊就诊和住院率均低于EBD组。
  • 两组手术率和30天不良事件无显著差异。

核心结论

  • 对于短段克罗恩病狭窄,内镜下狭窄切开术(ES)较内镜下球囊扩张(EBD)与更低的1年临床复发和再干预相关。
  • 研究支持ES作为专家中心有前景的内镜策略,但需多中心研究验证。

研究设计与样本

  • 随机对照试验,纳入18-65岁有症状且标准内镜可及的短段(<3 cm)克罗恩病狭窄成人患者。
  • 共筛查164例,随机106例(EBD n=53;ES n=53),1:1分配。
  • 主要结局为1年临床复发;次要结局包括1年再干预、手术、狭窄相关急诊就诊和住院;30天评估安全性。

主要发现

  • 12个月时间-事件分析中,EBD与更高的临床复发风险(HR 2.27,95% CI 1.23-4.18)和再干预风险(HR 2.40,95% CI 1.23-4.68)相关。

临床怎么用

  • 在专家中心,对于标准内镜可及的短段(<3 cm)克罗恩病狭窄,可考虑将ES作为EBD的替代内镜治疗选择。
  • ES可能降低1年临床复发、再干预、急诊就诊和住院风险,但需在多中心研究中进一步验证。

局限性

  • 研究结果支持ES在专家中心的应用,但需多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic balloon dilation (EBD) is the standard therapy for Crohn's disease (CD) strictures but is limited by recurrence and reinterventions. Randomized comparative data on endoscopic stricturotomy (ES) vs EBD are lacking. METHODS: In this randomized controlled trial, adults (18-65 years) with symptomatic CD and short (<3 cm) strictures accessible by standard endoscopy were randomly assigned (1:1) to EBD or ES. The primary outcome was clinical recurrence at 1 year. Secondary outcomes at 1 year included reintervention, surgery, and stricture-related emergency visits and hospitalisation; safety was assessed at 30 days. Time-to-event analyses were censored at 12 months. RESULTS: Of 164 patients screened, 106 were randomised (EBD n=53; ES n=53). In the intention-to-treat population, clinical recurrence at 1 year was lower with ES than EBD (30.1% vs 54.7%; p=0·01), as were reintervention (24.5% vs 49.1%; p=0·01), emergency visits (18.9% vs 50.9%; p=0·001), and hospitalisations (15.1% vs 34%; p=0·02). Surgery did not differ significantly (1.9% vs 11.3%; p=0·11). In 12-month time-to-event analyses, EBD was associated with higher hazards of clinical recurrence (HR 2.27, 95% CI 1.23-4.18) and reintervention (HR 2.40, 95% CI 1.23-4.68), with consistent findings for emergency visits and hospitalisation. Adverse events were similar (13·2% vs 22.6%; p=0·30). CONCLUSION: ES was associated with lower 1-year clinical recurrence and reintervention than EBD for short CD strictures. These findings support ES as a promising endoscopic strategy in expert centres and warrant validation in multicentre studies. (ClinicalTrials.gov: NCT05521867).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Pal, Pooja, Naaz, et al. Endoscopic Balloon Dilation Versus Endoscopic Stricturotomy for Short Crohn's Disease Strictures: The BEST-CD Randomized Trial. Clin Gastroenterol Hepatol. 2026. PMID: 42950934. doi:10.1016/j.cgh.2026.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。